Humana

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Humana 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About HUM

Humana Inc. engages in the provision of health insurance services. It operates through the Insurance and CenterWell segments. 

CEO
James A. Rechtin
CEOJames A. Rechtin
Employees
67,060
Employees67,060
Headquarters
Louisville, Kentucky
HeadquartersLouisville, Kentucky
Founded
1961
Founded1961
Employees
67,060
Employees67,060

HUM Key Statistics

Market cap
41.92B
Market cap41.92B
Price-Earnings ratio
35.05
Price-Earnings ratio35.05
Dividend yield
1.08%
Dividend yield1.08%
Average volume
1.08M
Average volume1.08M
High today
$351.57
High today$351.57
Low today
$333.55
Low today$333.55
Open price
$338.15
Open price$338.15
Volume
994.08K
Volume994.08K
52 Week high
$351.57
52 Week high$351.57
52 Week low
$163.11
52 Week low$163.11

Stock Snapshot

With a market cap of 41.92B, Humana(HUM) trades at $349.17. The stock has a price-to-earnings ratio of 35.05 and currently yields dividends of 1.1%.

As of 2026-06-04, Humana(HUM) stock has fluctuated between $333.55 and $351.57. The current price stands at $349.17, placing the stock +4.7% above today's low and -0.7% off the high.

The Humana(HUM)'s current trading volume is 994.08K, compared to an average daily volume of 1.08M.

During the past year, Humana(HUM) stock moved between $163.11 at its lowest and $351.57 at its peak.

During the past year, Humana(HUM) stock moved between $163.11 at its lowest and $351.57 at its peak.

HUM News

TipRanks 6h
Humana price target raised to $249 from $217 at Morgan Stanley

Morgan Stanley raised the firm’s price target on Humana (HUM) to $249 from $217 and keeps an Underweight rating on the shares. Managed care stocks have been “gr...

Simply Wall St 10h
Humana Valuation Check As New Orlando Pharmacy Center Expands Mail Order Capacity - simplywall.st

...

Humana Valuation Check As New Orlando Pharmacy Center Expands Mail Order Capacity - simplywall.st
Nasdaq 3d
PG&E Moves Up In Market Cap Rank, Passing Humana

In the latest look at the underlying components of the S&P 500 ordered by largest market capitalization, PG&E Corp (Symbol: PCG) has taken over the #272 spot fr...

PG&E Moves Up In Market Cap Rank, Passing Humana

Analyst ratings

66%

of 29 ratings
Buy
27.6%
Hold
65.5%
Sell
6.9%

More HUM News

TipRanks 3d
Humana Reaffirms 2026 Earnings Guidance in Investor Meetings

Unlock trusted, data-backed investing tools with TipRanks Premium, from analyst ratings and forecasts to breaking news and portfolio analysis. Discover high-co...

TipRanks 3d
Humana AGM Approves Dividend, Share Issuance Mandate and Capital Changes

Unlock trusted, data-backed investing tools with TipRanks Premium, from analyst ratings and forecasts to breaking news and portfolio analysis. Discover high-co...

Simply Wall St 6d
How Humana’s New Orlando CenterWell Mail Hub May Reframe Its Pharmacy Ambitions

Humana Inc. recently began full operations at its new US$83 million, 162,000-square-foot CenterWell Pharmacy mail-order distribution center in Orlando, which ca...

How Humana’s New Orlando CenterWell Mail Hub May Reframe Its Pharmacy Ambitions

People also own

Based on the portfolios of people who own HUM. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.